Table of Contents 1 Inadequately Controlled Type-II Diabetes Treatment Market Overview 1.1 Product Overview and Scope of Inadequately Controlled Type-II Diabetes Treatment 1.2 Classification of Inadequately Controlled Type-II Diabetes Treatment by Types 1.2.1 Global Inadequately Controlled Type-II Diabetes Treatment Revenue Comparison by Types (2017-2023) 1.2.2 Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Types in 2017 1.2.3 Adult 1.2.4 Child 1.3 Global Inadequately Controlled Type-II Diabetes Treatment Market by Application 1.3.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Hospital 1.3.3 Research 1.4 Global Inadequately Controlled Type-II Diabetes Treatment Market by Regions 1.4.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Inadequately Controlled Type-II Diabetes Treatment Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Inadequately Controlled Type-II Diabetes Treatment Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Inadequately Controlled Type-II Diabetes Treatment Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Inadequately Controlled Type-II Diabetes Treatment Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Inadequately Controlled Type-II Diabetes Treatment Status and Prospect (2013-2023) 1.5 Global Market Size of Inadequately Controlled Type-II Diabetes Treatment (2013-2023) 2 Manufacturers Profiles 2.1 Sanofi S.A. 2.1.1 Business Overview 2.1.2 Inadequately Controlled Type-II Diabetes Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Sanofi S.A. Inadequately Controlled Type-II Diabetes Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.2 Boehringer Ingelheim GmbH 2.2.1 Business Overview 2.2.2 Inadequately Controlled Type-II Diabetes Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Boehringer Ingelheim GmbH Inadequately Controlled Type-II Diabetes Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.3 Eli Lilly and Company 2.3.1 Business Overview 2.3.2 Inadequately Controlled Type-II Diabetes Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Eli Lilly and Company Inadequately Controlled Type-II Diabetes Treatment Revenue, Gross Margin and Market Share (2016-2017) 3 Global Inadequately Controlled Type-II Diabetes Treatment Market Competition, by Players 3.1 Global Inadequately Controlled Type-II Diabetes Treatment Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Inadequately Controlled Type-II Diabetes Treatment Players Market Share 3.2.2 Top 10 Inadequately Controlled Type-II Diabetes Treatment Players Market Share 3.3 Market Competition Trend 4 Global Inadequately Controlled Type-II Diabetes Treatment Market Size by Regions 4.1 Global Inadequately Controlled Type-II Diabetes Treatment Revenue and Market Share by Regions 4.2 North America Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 4.3 Europe Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 4.5 South America Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 5 North America Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries 5.1 North America Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries (2013-2018) 5.2 USA Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 5.3 Canada Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 5.4 Mexico Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 6 Europe Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries 6.1 Europe Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries (2013-2018) 6.2 Germany Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 6.3 UK Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 6.4 France Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 6.5 Russia Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 6.6 Italy Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries 7.1 Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries (2013-2018) 7.2 China Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 7.3 Japan Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 7.4 Korea Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 7.5 India Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 8 South America Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries 8.1 South America Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries (2013-2018) 8.2 Brazil Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 8.3 Argentina Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 8.4 Colombia Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Inadequately Controlled Type-II Diabetes Treatment by Countries 9.1 Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries (2013-2018) 9.2 Saudi Arabia Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 9.3 UAE Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 9.4 Egypt Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 9.5 Nigeria Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 9.6 South Africa Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) 10 Global Inadequately Controlled Type-II Diabetes Treatment Market Segment by Type 10.1 Global Inadequately Controlled Type-II Diabetes Treatment Revenue and Market Share by Type (2013-2018) 10.2 Global Inadequately Controlled Type-II Diabetes Treatment Market Forecast by Type (2018-2023) 10.3 Adult Revenue Growth Rate (2013-2023) 10.4 Child Revenue Growth Rate (2013-2023) 11 Global Inadequately Controlled Type-II Diabetes Treatment Market Segment by Application 11.1 Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Application (2013-2018) 11.2 Inadequately Controlled Type-II Diabetes Treatment Market Forecast by Application (2018-2023) 11.3 Hospital Revenue Growth (2013-2018) 11.4 Research Revenue Growth (2013-2018) 12 Global Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2018-2023) 12.1 Global Inadequately Controlled Type-II Diabetes Treatment Market Size Forecast (2018-2023) 12.2 Global Inadequately Controlled Type-II Diabetes Treatment Market Forecast by Regions (2018-2023) 12.3 North America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) 12.4 Europe Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) 12.6 South America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Inadequately Controlled Type-II Diabetes Treatment Picture Table Product Specifications of Inadequately Controlled Type-II Diabetes Treatment Table Global Inadequately Controlled Type-II Diabetes Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Types in 2017 Figure Adult Picture Figure Child Picture Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) by Application (2013-2023) Figure Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Applications in 2017 Figure Hospital Picture Figure Research Picture Table Global Market Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) and Growth Rate (2013-2023) Table Sanofi S.A. Basic Information, Manufacturing Base and Competitors Table Sanofi S.A. Inadequately Controlled Type-II Diabetes Treatment Type and Applications Table Sanofi S.A. Inadequately Controlled Type-II Diabetes Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors Table Boehringer Ingelheim GmbH Inadequately Controlled Type-II Diabetes Treatment Type and Applications Table Boehringer Ingelheim GmbH Inadequately Controlled Type-II Diabetes Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors Table Eli Lilly and Company Inadequately Controlled Type-II Diabetes Treatment Type and Applications Table Eli Lilly and Company Inadequately Controlled Type-II Diabetes Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) by Players (2013-2018) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Players (2013-2018) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Players in 2016 Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Players in 2017 Figure Global Top 5 Players Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share in 2017 Figure Global Top 10 Players Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share in 2017 Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) by Regions (2013-2018) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Regions (2013-2018) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Regions (2013-2018) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Regions in 2017 Figure North America Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Europe Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure South America Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Table North America Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries (2013-2018) Table North America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries (2013-2018) Figure North America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries (2013-2018) Figure North America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries in 2017 Figure USA Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Canada Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Mexico Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Table Europe Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) by Countries (2013-2018) Figure Europe Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries (2013-2018) Figure Europe Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries in 2017 Figure Germany Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure UK Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure France Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Russia Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Italy Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Table Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries in 2017 Figure China Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Japan Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Korea Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure India Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Southeast Asia Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Table South America Inadequately Controlled Type-II Diabetes Treatment Revenue by Countries (2013-2018) Table South America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries (2013-2018) Figure South America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries (2013-2018) Figure South America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries in 2017 Figure Brazil Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Argentina Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Colombia Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Table Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share by Countries in 2017 Figure Saudi Arabia Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure UAE Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Egypt Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure Nigeria Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Figure South Africa Inadequately Controlled Type-II Diabetes Treatment Revenue and Growth Rate (2013-2018) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) by Type (2013-2018) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Type (2013-2018) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Type (2013-2018) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Type in 2017 Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue Forecast by Type (2018-2023) Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Share Forecast by Type (2018-2023) Figure Global Adult Revenue Growth Rate (2013-2018) Figure Global Child Revenue Growth Rate (2013-2018) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue by Application (2013-2018) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Application (2013-2018) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Application (2013-2018) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Share by Application in 2017 Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue Forecast by Application (2018-2023) Figure Global Inadequately Controlled Type-II Diabetes Treatment Market Share Forecast by Application (2018-2023) Figure Global Hospital Revenue Growth Rate (2013-2018) Figure Global Research Revenue Growth Rate (2013-2018) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Inadequately Controlled Type-II Diabetes Treatment Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Inadequately Controlled Type-II Diabetes Treatment Revenue Market Share Forecast by Regions (2018-2023) Figure North America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) Figure Europe Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) Figure Asia-Pacific Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) Figure South America Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023) Figure Middle East and Africa Inadequately Controlled Type-II Diabetes Treatment Revenue Market Forecast (2018-2023)

Sanofi S.A. Boehringer Ingelheim GmbH Eli Lilly and Company